Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | UNK | — |
Patient did not receive both vials of Menveo; Patient did not receive both vials of Menveo; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a adult female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received the 1st dose of Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Patient did not receive both vials of Menveo) and inappropriate dose of vaccine administered (Verbatim: Patient did not receive both vials of Menveo). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 04-FEB-2025 The Healthcare Professional reported that patient received the 1st dose of Menveo vaccine but did not received both vials. The patient received only adjuvant of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.